Testing the protective efficacy in mice of a whole-virion inactivated purified influenza A H5N1 vaccine for human use against lethal dose of this virus. Method: Vaccinate to mice Balb / c 6 - 7 weeks-old 2 injections 2 weeks interval with doses of 10 and 1mcg/0, 5ml / IP (in abdomen cavity).